|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 651.91 USD | +0.11% |
|
-1.89% | -15.54% |
| 07-22 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 07-21 | Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 686.36 | 686.36 | 803.17 |
| Spread/Res. | -5.02% | -5.02% | -18.83% |
| Spread/Supp. | +2.59% | +8.53% | +16.41% |
| Support | 635.45 | 600.66 | 560 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
